Synapse - Find an Expert

Results (44)

Pathologic response and histologic features of cytoreductive nephrectomy (CN) following immunotherapy (IO) for patients with metastatic renal cell carcinoma (RCC)

Meeting Abstract

Wu, C. Y.; Reese, S.; Al-Ahmadie, H.; Fine, S.; Gopalan, A.; Sarungbam, J.; Sirintrapun, S. J.; Kotecha, R.; Voss, M.; Coleman, J.; more...
Laboratory Investigation (2023)

Fulltext@MSK | Save

Distinct genomic alterations in radiation-induced angiosarcoma compared to other radiation-associated sarcoma histologies: Rationale for individualized therapeutic targeting

Meeting Abstract

Dermawan, J.; Chi, P.; Tap, W.; Rosenbaum, E.; D'Angelo, S.; Alektiar, K.; Antonescu, C.
Laboratory Investigation (2023)

Fulltext@MSK | Save

Applying lymphgen classification to a clinically validated 400-gene targeted next-generation sequencing (NGS) panel in diffuse large b-cell lymphoma (DLBCL)

Meeting Abstract

Zhu, M.; Drill, E.; Joffe, E.; Arcila, M.; Dogan, A.
Laboratory Investigation (2022)

Fulltext@MSK | Save

UV genomic signature classifies lung melanomas of unknown primary as metastases from occult cutaneous melanomas

Meeting Abstract

Yang, C.; Sanchez-Vega, F.; Shoushtari, A.; Ladanyi, M.; Travis, W.; Busam, K.; Rekhtman, N.
Laboratory Investigation (2020)

Fulltext@MSK | Save

Frequent TET2 mutations in histiocytic neoplasms

Meeting Abstract

Liu, Y.; Petrova-Drus, K.; Durham, B.; Baik, J.; Sigler, A.; Rampal, R.; Abdel-Wahab, O.; Diamond, E.; Dogan, A.; Yabe, M.
Laboratory Investigation (2020)

Fulltext@MSK | Save

Single-cell evaluation of myelodysplastic syndrome stem cells identifies determinants of hypomethylating agent response and a novel prognostic gene signature

Meeting Abstract

Javidiparsijani, S.; Dolgalev, I.; Vijay, P.; Gonzalez, M. D.; Devlin, S.; Klimek, V.; Chung, S.; Mason, C.; Park, C.
Laboratory Investigation (2020)

Fulltext@MSK | Save

Clonal hematopoiesis (CH) in angioimmunoblastic T-cell lymphoma (AITL) with divergent evolution to myeloid neoplasms (MNs)

Meeting Abstract

Lewis, N.; Petrova-Drus, K.; Epstein-Peterson, Z.; Huet, S.; Gao, Q.; Sigler, A.; Baik, J.; Kumar, A.; Horwitz, S.; Zhang, Y.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

Erythroid/megakaryoblastic leukemia with TP53 and RUNX1 mutations frequently occurs in blast transformation of Philadelphia chromosome-negative myeloproliferative neoplasms: A single-institution experience with 56 cases